跳至主要内容
临床试验/NCT02960828
NCT02960828Unknown不适用

Focal Subthreshold Laser Treatment for Macular Drusen

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2016年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
21
试验地点
1
主要终点
Change in drusen size

研究概览

简要总结

This study aims to validate the efficacy and safety of subthreshold laser photocoagulation on high-risk macular drusen in early age-related macular degeneration which has a high risk of conversion to exudative AMD.

详细描述

SAVE Study (Stop Early Age-related Macular Degeneration form Vision Loss Eternally)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Drusen in both eyes examined under fundoscopy
  • At least one of the eyes must have high-risk soft drusen
  • BCVA below ETDRS 83 letters
  • Patient with consent to participate

排除标准

  • Prior diagnosis with choroidal neovascularization
  • Exudative AMD in at least one eye
  • If the patient has only one visually effective eye (last eye)
  • Other macula or retinal diseases than age-related macular degeneration

研究组 & 干预措施

Intervention-"Device:_Laser"

Experimental
  • Subthreshold focal photocoagulation
  • Intravitreal Anti-vascular endothelial growth factor (Anti-VEGF) injection

干预措施: Subthreshold Laser Photocoagulation (Procedure)

Intervention-"Device:_Laser"

Experimental
  • Subthreshold focal photocoagulation
  • Intravitreal Anti-vascular endothelial growth factor (Anti-VEGF) injection

干预措施: intravitreal Anti-VEGF injection (Drug)

Intervention-"Device:_Laser"

Experimental
  • Subthreshold focal photocoagulation
  • Intravitreal Anti-vascular endothelial growth factor (Anti-VEGF) injection

干预措施: Subthreshold Laser (Device)

结局指标

主要结局

Change in drusen size

时间窗: 3 month interval

次要结局

  • Change in drusen distribution(3 month interval)
  • Best Corrected Visual Acuity (BCVA)(3 months interval)
  • Change in autofluorescence(3 month interval)
  • Choroidal Neovascularization(3 months interval)
  • Contrast Sensitivity(3 months interval)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kyu Hyung Park

Professor, Chief of department of Ophthalmology

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验

"Stop Early Age-related Macular Degeneration (AMD)... | 临床试验